Phreesia
About: Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
Employees: 1,438
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
79% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 19
46% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 48
9% more capital invested
Capital invested by funds: $1.15B [Q2] → $1.25B (+$102M) [Q3]
8% more funds holding
Funds holding: 176 [Q2] → 190 (+14) [Q3]
0.8% more ownership
Funds ownership: 94.67% [Q2] → 95.47% (+0.8%) [Q3]
33% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $15.7M
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$29
6%
upside
Avg. target
$31
15%
upside
High target
$35
28%
upside
7 analyst ratings
7 positive
100%
0 neutral
0%
0 negative
0%
Citigroup Daniel Grosslight 35% 1-year accuracy 8 / 23 met price target | 28%upside $35 | Buy Maintained | 10 Jan 2025 |
Needham Ryan MacDonald 56% 1-year accuracy 38 / 68 met price target | 6%upside $29 | Buy Reiterated | 10 Jan 2025 |
Keybanc Scott Schoenhaus 19% 1-year accuracy 7 / 36 met price target | 10%upside $30 | Overweight Maintained | 8 Jan 2025 |
RBC Capital Sean Dodge 45% 1-year accuracy 20 / 44 met price target | 17%upside $32 | Outperform Upgraded | 8 Jan 2025 |
Truist Securities Jailendra Singh 31% 1-year accuracy 11 / 35 met price target | 24%upside $34 | Buy Maintained | 11 Dec 2024 |
Financial journalist opinion
Positive
Zacks Investment Research
1 week ago
Phreesia (PHR) Upgraded to Buy: Here's Why
Phreesia (PHR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Positive
Zacks Investment Research
1 week ago
Should You Buy Phreesia (PHR) After Golden Cross?
From a technical perspective, Phreesia, Inc. (PHR) is looking like an interesting pick, as it just reached a key level of support. PHR's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts See a 25% Upside in Phreesia (PHR): Can the Stock Really Move This High?
The consensus price target hints at a 25% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Positive
Seeking Alpha
1 month ago
Phreesia Has Turned The Corner, Can It Continue To Mend?
Phreesia's Q3 earnings show solid revenue growth, but customer growth is decelerating, impacting overall performance. Fiscal 2025 guidance improved with higher EBITDA and tighter revenue estimates, while fiscal 2026 projects slower revenue growth but significant EBITDA improvement. Strong cash flow and disciplined expense management are encouraging, with the company maintaining positive cash flows and holding $82M in cash.
Neutral
Seeking Alpha
1 month ago
Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript
Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript
Neutral
Zacks Investment Research
1 month ago
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Phreesia (PHR) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Negative
Zacks Investment Research
1 month ago
Phreesia (PHR) Reports Q3 Loss, Tops Revenue Estimates
Phreesia (PHR) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.58 per share a year ago.
Neutral
Business Wire
1 month ago
Phreesia Announces Third Quarter Fiscal 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2024. "We are excited about the future here at Phreesia,” said CEO and Co-Founder Chaim Indig. “Our network continues to grow, adoption of our current offerings is increasing, and we are beginning to see the promise of new solutions we are investing in.” Please visit the Phreesia investor relations website.
Neutral
Zacks Investment Research
1 month ago
Curious about Phreesia (PHR) Q3 Performance? Explore Wall Street Estimates for Key Metrics
Evaluate the expected performance of Phreesia (PHR) for the quarter ended October 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Neutral
Business Wire
2 months ago
Phreesia Named to The Software Report's “Top 100 Software Companies” for the Third Consecutive Year
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year.
Charts implemented using Lightweight Charts™